Octreotide Dosage Guide
95/100 confidenceComplete guide to Octreotide dosing protocols, administration methods, and safety considerations for research purposes.
NOT Medical Advice
The dosage and calculator information provided is for educational and research purposes only. Peptides are not approved by the FDA for human use. Individual responses vary significantly. Always consult with a qualified healthcare professional before making any decisions related to peptide research or use.
Dosage Overview
Dose Range
50 mcg - 100 mcg
Route
multiple
Frequency
3x daily
Cycle Length
4 weeks
Reconstitution
Vial Size
5 mg
BAC Water
2 ml
Concentration
2,500 mcg/ml
Detailed Dosage Information
Varies by indication. Acromegaly: 50-100mcg three times daily initially, up to 500mcg TID. LAR (long-acting): 20-30mg IM every 4 weeks.
Administration Method
Subcutaneous injection for immediate-release (between meals). Intramuscular for LAR depot form. Requires monitoring of gallbladder, glucose, and thyroid.
Research Use Only: All dosage ranges and calculations are derived from published research literature and are provided for educational purposes. These are not prescriptions or medical recommendations. Consult a healthcare professional before any use.
Quick Calculator
Concentration: 2,500 mcg/ml
Volume to inject: 0.02 ml
Syringe units (U-100): 2.0 units
Pre-filled with Octreotide defaults. Adjust values as needed.
Research Backing
Full FDA prescribing information \+ large Phase 3 trials (PROMID, CLARINET) for neuroendocrine tumors; decades of clinical use in endocrinology.
Side Effects to Monitor
GI effects (diarrhea, nausea, abdominal pain), gallstones (up to 25% of long-term users), injection site reactions, and blood glucose changes.
Safety Considerations & Risks
High gallstone risk with chronic use. May cause or worsen hyperglycemia or hypoglycemia. Cardiac conduction abnormalities possible.